The outlook of companies tied to blockbuster drugs like Viagra presents a challenging investment picture. While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the expiry in key territories has introduced considerable uncertainty . Investors are now facing the consequences of rival medicat